Treatment of severe alopecia areata with intralesional steroid injections

Journal of Drugs in Dermatology

Volumn 8, Issue 10, 2009, Pages 909-912

  Chang, Kyung Hee ^a   Rojhirunsakool, Salinee ^a   Goldberg, Lynne J ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; TRIAMCINOLONE ACETONIDE; GLUCOCORTICOID; LOCAL ANESTHETIC AGENT;

ADOLESCENT; ADULT; ALOPECIA AREATA; ARTICLE; ATROPHY; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; PHYSICAL EXAMINATION; TOPICAL ANESTHESIA; TREATMENT RESPONSE; HOSPITALIZATION; INTRALESIONAL DRUG ADMINISTRATION; MIDDLE AGED; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ALOPECIA AREATA; ANESTHETICS, LOCAL; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE;

EID: 70350719499     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Fiedler VC, Alaiti S. Treatment of alopecia areata. Dermatol Clin. 1996;14(4):733-738. (Pubitemid 26322541)
2. Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol. 2000;42(4):549-566.
3. Price VH. Therapy of alopecia areata: On the cusp and in the future. J Investig Dermatol Symp Proc. 2003;8(2):207-211. (Pubitemid 37222832)
4. Freyschmidt-Paul P, Happle R, McElwee KJ, Hoffmann R. Alopecia areata: Treatment of today and tomorrow. J Investig Dermatol Symp Proc. 2003;8(1):12-17. (Pubitemid 36900484)
5. MacDonald Hull SP, Wood ML, Hutchinson PE, et al. Guidelines for the management of alopecia areata. Br J Dermatol. 2003;149(4):692-696.
6. Olsen E, Hordinsky M, McDonald-Hull S, et al. Alopecia areata investigational assessment guidelines. J Am Acad Dermatol. 1999;40(2):242-246. (Pubitemid 29072802)
7. Shapiro J. Alopecia areata. Update on therapy. Dermatol Clin. 1993;11(1):35-46.
8. Shapiro J, Price VH. Hair regrowth. Therapeutic agents. Dermatol Clin. 1998;16(2):341-356.
9. Proceedings of the First International Research Workshop on Alopecia Areata. J Invest Dermatol. 1991;96(Suppl):67S-98S.
10. Abell E, Munro DD. Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injection. Br J Dermatol. 1973;88(1):55-59.
11. Orentreich N, Sturm HM, Weidman AI, Pelzig A. Local injection of steroids and hair regrowth in alopecias. Arch Dermatol. 1960;82:894-902.
12. Fülöp E. Mechanism of local skin atrophy caused by intradermally injected corticosteroids. Dermatologica. 1976;152(Suppl 1):139-146.
13. Happle R, Echternacht K. Induction of hair growth in alopecia areata with D.N.C.B. Lancet. 1977;2(8046):1002-1003. (Pubitemid 8215387)
14. Wiseman MC, Shapiro J, MacDonald N, Lui H. Predictive model for immunotherapy of alopecia areata with diphencyprone. Arch Dermatol. 2001;137(8):1063-1068. (Pubitemid 32756464)
15. Cotellessa C, Peris K, Caracciolo E, et al. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata. J Am Acad Dermatol. 2001;44(1):73-76. (Pubitemid 32110565)
16. Tosti A, Guidetti MS, Bardazzi F, Misciali C. Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis. J Am Acad Dermatol. 1996;35:199-201.
17. Micali G, Licastro-Cicero R, Nasca MR. Treatment of alopecia areata with squaric acid dibutylester. Int J Dermatol. 1996;35:52-56. (Pubitemid 26037045)
18. Shapiro J. Topical immunotherapy in the treatment of chronic severe alopecia areata. Dermatol Clin. 1993;11(3):611-617. (Pubitemid 23229741)
19. Hoffmann R, Happle R. Topical immunotherapy in alopecia areata: What, how, and why? Dermatol Clin. 1996;14(4):739-744. (Pubitemid 26322542)
20. Compliance Policy Guidance for FDA Staff and Industry. Chapter 4, Subchapter 460, Section 460.200 Pharmacy Compounding. Available at: http://www.fda.gov/ora/compliance-ref/cpg/cpgdrg/cpg 460-200, reissued May 29, 2002.
21. Rallis E, Nasiopoulou A, Kouskoukis C, et al. Oral administration of cyclosporin A in patients with severe alopecia areata. Int J Tissue React. 2005;27(3):107-110. (Pubitemid 41723726)
22. Joly P. The use of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia totalis or universalis. J Am Acad Dermatol. 2006;55(4):632-636. (Pubitemid 44436626)
23. Peereboom-Wynia JD, van Joost T, Stolz E, Prins ME. Markers of immunologic injury in progressive alopecia areata. J Cutan Pathol. 1986;13(5):363-369. (Pubitemid 16009122)
24. Tobin DJ. Morphological analysis of hair follicles in alopecia areata. Microsc Res Tech. 1997;38(4):443-451. (Pubitemid 27377656)
25. Tobin DJ, Fenton DA, Kendall MD. Ultrastructural study of exclamation- mark hair shafts in alopecia areata. J Cutan Pathol. 1990;17(6):348-354.
26. Lacarrubba F, Dall'Oglio F, Rita Nasca M, Micali G. Videodermatoscopy enhances diagnostic capability in some forms of hair loss. Am J Clin Dermatol. 2004;5(3):205-208. (Pubitemid 38901550)